Roger M. Perlmutter - 06 Feb 2026 Form 4 Insider Report for Eikon Therapeutics, Inc. (EIKN)

Reporting relationship: Chief Executive Officer and Director, Director
Issuer ticker: EIKN
Reported as of: 06 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Feb 2026, 17:06:14 UTC
Prior SEC filing: 04 Feb 2026
Next SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Benjamin Thorner, Attorney-in-Fact

Key filing fact

Roger M. Perlmutter filed Form 4 for Eikon Therapeutics, Inc. (EIKN) on 10 Feb 2026.

Key facts

This page summarizes Roger M. Perlmutter's Form 4 filing for Eikon Therapeutics, Inc. (EIKN).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 10 Feb 2026, 17:06.

Change

Previous filing in this sequence was filed on 04 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001184228 Primary reporting owner

PERLMUTTER ROGER M

Relationship: Chief Executive Officer and Director, Director
Address: C/O EIKON THERAPEUTICS, INC., 230 HARRIET TUBMAN WAY, MILLBRAE
Signature: /s/ Benjamin Thorner, Attorney-in-Fact
Signature date: 10 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EIKN transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +284,857
Change %
Price
Shares after: 284,857
Date: 06 Feb 2026
Ownership: See Footnote
Footnotes: F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EIKN transaction Derivative

Series A-1 Preferred Stock

Conversion of derivative security

Transaction value
Shares: -1,268,891
Change %: -100%
Price
Shares after: 0
Date: 06 Feb 2026
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 170,143
Exercise price
Footnotes: F1, F3

EIKN transaction Derivative

Series D Preferred Stock

Conversion of derivative security

Transaction value
Shares: -855,512
Change %: -100%
Price
Shares after: 0
Date: 06 Feb 2026
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 114,714
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date.

Footnote F2

The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.

Footnote F3

The securities are held indirectly by the Reporting Person through Perlmutter Consulting, Inc. for the benefit of the Reporting Person. The Reporting Person had the sole pecuniary interest in the securities.

SEC remarks

Chief Executive Officer and Director